Literature DB >> 3117705

Unusual mechanism of pathogenicity of Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

B Tümmler1.   

Abstract

A Pseudomonas aeruginosa strain was isolated from a patient with cystic fibrosis and was found capable of growing within polymorphonuclear leucocytes. As illustrated by electron microscopy, several mechanisms accounted for the intracellular growth: (a) Cell division occurred within the lysosomes; (b) The fusion of the phagosome with the primary lysosome was inhibited; (c) The phagosomal membrane disintegrated, and the bacteria grew within the cytosol; (d) Cytosolic material was separated from the surroundings by bacterial membranes, and subsequently the bacteria coated with host material were released from the leucocyte. The patient suffered from several severe acute pulmonary exacerbations as long as the intracellularly growing variant was detectable in his sputum. After the strain had been eliminated by antibiotic therapy the patient improved (from stage two to one).

Entities:  

Mesh:

Year:  1987        PMID: 3117705     DOI: 10.1007/bf01644144

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  The mycoside capsule of Mycobacterium Avium 357.

Authors:  P Draper
Journal:  J Gen Microbiol       Date:  1974-08

Review 2.  Mechanisms of bacterial virulence.

Authors:  R R Brubaker
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

Review 3.  Immunity to intracellular bacteria.

Authors:  F M Collins; S G Campbell
Journal:  Vet Immunol Immunopathol       Date:  1982-01       Impact factor: 2.046

4.  Intracellular killing of different strains of Pseudomonas aeruginosa by human leucocytes.

Authors:  E A Roe; R J Jones
Journal:  Br J Exp Pathol       Date:  1974-08

5.  In vitro effect of the slime of Pseudomonas aeruginosa on the function of human polymorphonuclear neutrophils.

Authors:  P F Laharrague; J X Corberand; G Fillola; B J Gleizes; A M Fontanilles; E Gyrard
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

6.  Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis.

Authors:  M B Goren; P D'Arcy Hart; M R Young; J A Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

7.  Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.

Authors:  R S Baltimore; M Mitchell
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

  7 in total
  6 in total

Review 1.  The Jeremiah Metzger Lecture. Microbial defenses against killing by phagocytes.

Authors:  G L Mandell; M O Frank
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

2.  Treatment of infections in patients with cystic fibrosis.

Authors:  M I Marks
Journal:  Infection       Date:  1987       Impact factor: 3.553

3.  Genome-wide transcriptional profiling of the steady-state response of Pseudomonas aeruginosa to hydrogen peroxide.

Authors:  Prabhakar Salunkhe; Tanja Töpfer; Jan Buer; Burkhard Tümmler
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

4.  Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection.

Authors:  S M Fleiszig; T S Zaidi; E L Fletcher; M J Preston; G B Pier
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Caenorhabditis elegans semi-automated liquid screen reveals a specialized role for the chemotaxis gene cheB2 in Pseudomonas aeruginosa virulence.

Authors:  Steven Garvis; Antje Munder; Geneviève Ball; Sophie de Bentzmann; Lutz Wiehlmann; Jonathan J Ewbank; Burkhard Tümmler; Alain Filloux
Journal:  PLoS Pathog       Date:  2009-08-07       Impact factor: 6.823

6.  Lung infection caused by Pseudomonas aeruginosa in a CD26/DPP4 deficient F344 rat model.

Authors:  M Neuhaus; A Munder; J Schipke; A Schmiedl
Journal:  Inflamm Res       Date:  2019-05-14       Impact factor: 4.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.